Combination of atr kinase inhibitors with 2,3-dihydroimidazo[1,2-c]quinazoline compounds
US-2021369724-A1 · Dec 2, 2021 · US
This page is not indexed by search engines while we improve data quality.
Patent family 63878439
This patent family groups 1 related publication across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 63878439 |
| Family type | — |
| Earliest priority | Oct 16, 2018 |
| First filing country | US |
| Member publications | 1 |
| Countries | US |
| Representative publication | US2021369724A1 — Combination of atr kinase inhibitors with 2,3-dihydroimidazo[1,2-c]quinazoline compounds |
Representative publication
Best representative member for this family based on priority and filing country.
US2021369724A1 — Combination of atr kinase inhibitors with 2,3-dihydroimidazo[1,2-c]quinazoline compounds (published Dec 2, 2021)
Member publications
Related publications in this family.